
Humana Inc. (HUM), a large-cap healthcare facility stock, has garnered a strong 93% rating from Validea's Pim van Vliet Multi-Factor Investor model, which prioritizes low volatility stocks with momentum and high net payout yields. This high score signifies strong interest from the model, driven by HUM's underlying fundamentals and valuation, particularly its low standard deviation, aligning with the model's core tenet that low volatility can lead to higher returns with less risk.
Humana Inc. (HUM) has scored a highly favorable 93% rating from Validea's Multi-Factor Investor model, a quantitative strategy based on the work of Pim van Vliet that prioritizes low-volatility stocks with strong momentum and high net payout yields. This score, considered indicative of strong interest, is primarily driven by HUM's successful performance on low-risk metrics, specifically passing the model's criteria for market capitalization and standard deviation. However, the model assigned a 'NEUTRAL' rating to HUM's 'Twelve Minus One Momentum' and 'Net Payout Yield'. This suggests that while the stock's low-volatility profile is a key strength aligning with the strategy's core tenet of achieving higher returns from lower-risk assets, its current momentum and shareholder return characteristics are only adequate and not the primary drivers of its high overall ranking.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
strongly positive
Sentiment Score
0.70
Ticker Sentiment